|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/22/2024 |
$1.76 |
$1.76 |
$1.67 |
$1.67 |
257.90K | 04/23/2024 |
$1.67 |
$1.73 |
$1.64 |
$1.68 |
290.20K | 04/24/2024 |
$1.68 |
$1.70 |
$1.62 |
$1.63 |
350.90K | 04/25/2024 |
$1.61 |
$1.64 |
$1.58 |
$1.60 |
286.30K | 04/26/2024 |
$1.60 |
$1.65 |
$1.59 |
$1.59 |
249.20K |
|
CytomX Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company. Co. is developing an antibody-based therapeutics created using its Probody® therapeutic technology platform. Co.'s products include: Praluzatamab ravtansine, which is an activated antibody-drug conjugates directed against CD166, a tumor target previously considered undruggable due to its high expression on normal tissues; CX-2029, which opens a therapeutic window for targeting CD71; Pacmilimab, which is a Probody therapeutic against PD-L1, a clinically and commercially validated cancer target; and BMS-986249 and BMS-986288, which is the Probody versions of ipilimumab. | |
|
CytomX Therapeutics (CTMX) has the following price history information. Looking back at CTMX historical stock prices for the last five trading days, on April 22, 2024, CTMX opened at $1.76, traded as high as $1.76 and as low as $1.67, and closed at $1.67. Trading volume was a total of 257.90K shares. On April 23, 2024, CTMX opened at $1.67, traded as high as $1.73 and as low as $1.64, and closed at $1.68. Trading volume was a total of 290.20K shares. On April 24, 2024, CTMX opened at $1.68, traded as high as $1.70 and as low as $1.62, and closed at $1.63. Trading volume was a total of 350.90K shares. On April 25, 2024, CTMX opened at $1.61, traded as high as $1.64 and as low as $1.58, and closed at $1.60. Trading volume was a total of 286.30K shares. On April 26, 2024, CTMX opened at $1.60, traded as high as $1.65 and as low as $1.59, and closed at $1.59. Trading volume was a total of 249.20K shares.
CTMX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into CytomX Therapeutics shares, starting with a $10,000 purchase of CTMX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
10/09/2015 |
|
End date: |
04/26/2024 |
|
Start price/share: |
$12.40 |
|
End price/share: |
$1.59 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-87.18% |
|
Average Annual Total Return: |
-21.35% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$1,281.94 |
|
Years: |
8.55 |
|
|
|
Date |
Close |
04/22/2024 | $1.67 | 04/23/2024 | $1.68 | 04/24/2024 | $1.63 | 04/25/2024 | $1.60 | 04/26/2024 | $1.59 |
|
|